Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Resverlogix to explore apabetalone for complement-mediated diseases

Sep. 29, 2015

Japan first country to approve omarigliptin

Sep. 28, 2015

FDA approves Tresiba for adults with type 1 or type 2 diabetes

Sep. 28, 2015

Regeneron and Sanofi's Praluent approved in E.U. for hypercholesterolemia

Sep. 28, 2015

EMA committee hands down positive opinion for Ravicti

Sep. 28, 2015

Coq2 and Plac8 genes in obesity-related type 2 diabetes

Sep. 28, 2015

Glucose-dependent peptide shows promise for diabetes

Sep. 25, 2015

Helsinn Healthcare divulges ghrelin receptor antagonists

Sep. 25, 2015

ZP-I-98: a novel GIP receptor agonist

Sep. 23, 2015

Bristol-Myers Squibb patents MGAT2 inhibitors

Sep. 23, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Molecular signatures show subtypes in neurodegenerative diseases
BioWorld Science
Parkinson’s disease is a progressive neurodegenerative disorder best known for its motor symptoms. However, a proportion of patients also develop dementia as the...
More than two to tango: multispecifics at ESMO TAT
BioWorld Science
Multispecifics took center stage at this year’s ESMO TAT, emerging as one of the hottest trends in oncology research. Unlike traditional small-molecule drugs or...